Evidence map›Paper›PMID 34163546›Full record

ArticleThe Neurohospitalist2021

Clinical Electroencephalography Findings and Considerations in Hospitalized Patients With Coronavirus SARS-CoV-2.

Neishay Ayub, Joseph Cohen, Jin Jing, Aayushee Jain, Ryan Tesh, Shibani S Mukerji, Sahar F Zafar, M Brandon Westover, Eyal Y Kimchi

Open access · bronzeAbstract read
In one paragraph

Article in The Neurohospitalist, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. The value of EEG attenuation in the prediction of outcome in COVID-19 patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  9. Article
  10. Article
  11. Severe Neurologic Complications of SARS-CoV-2.Current treatment options in neurology · 2021
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Neishay AyubDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Joseph CohenDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Jin JingDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Aayushee JainDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Ryan TeshDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Shibani S MukerjiDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-5677-6954
Sahar F ZafarDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
M Brandon WestoverDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Eyal Y KimchiDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0003-4327-1102
Massachusetts General Hospital · US

Funding

Multimodal Network Connectivity Architecture (MOCA) of the Brain and its Role in the Recovery of Consciousness in Comatose Cardiac Arrest PatientsR01NS102574 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GREER, DAVID MATTHEW, WU, ONA · 2018 to 2022
$3.4M
Investigation of Sleep in the Intensive Care Unit (ICU-SLEEP)R01NS102190 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WESTOVER, MICHAEL BRANDON · 2018 to 2022
$3.2M
Big Data and Deep Learning for the Interictal-Ictal-Injury ContiuumR01NS107291 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WESTOVER, MICHAEL BRANDON · 2018 to 2022
$2.8M
Optimizing anti-epileptic drug treatment in acute brain injuryK23NS114201 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ZAFAR, SAHAR F · 2019 to 2023
$1.0M
Quantitative Monitoring and Control of Sedation and Pain in the ICU EnvironmentK23NS090900 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WESTOVER, MICHAEL BRANDON · 2014 to 2018
$988k
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-InfectionK23MH115812 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MUKERJI, SHIBANI SHARON · 2018 to 2022
$926k
NIMH NIH HHS K23 MH115812NINDS NIH HHS K23 NS090900NINDS NIH HHS K23 NS114201NINDS NIH HHS R01 NS102190NINDS NIH HHS R01 NS102574NINDS NIH HHS R01 NS107291
6 · The paper itself

Abstract

background and purposeReports have suggested that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurologic manifestations including encephalopathy and seizures. However, there has been relatively limited electrophysiology data to contextualize these specific concerns and to understand their associated clinical factors. Our objective was to identify EEG abnormalities present in patients with SARS-CoV-2, and to determine whether they reflect new or preexisting brain pathology.

methodsWe studied a consecutive series of hospitalized patients with SARS-CoV-2 who received an EEG, obtained using tailored safety protocols. Data from EEG reports and clinical records were analyzed to identify EEG abnormalities and possible clinical associations, including neurologic symptoms, new or preexisting brain pathology, and sedation practices.

resultsWe identified 37 patients with SARS-CoV-2 who underwent EEG, of whom 14 had epileptiform findings (38%). Patients with epileptiform findings were more likely to have preexisting brain pathology (6/14, 43%) than patients without epileptiform findings (2/23, 9%; p = 0.042). There were no clear differences in rates of acute brain pathology. One case of nonconvulsive status epilepticus was captured, but was not clearly a direct consequence of SARS-CoV-2. Abnormalities of background rhythms were common, as may be seen in systemic illness, and in part associated with recent sedation (p = 0.022).

conclusionsEpileptiform abnormalities were common in patients with SARS-CoV-2 referred for EEG, but particularly in the context of preexisting brain pathology and sedation. These findings suggest that neurologic manifestations during SARS-CoV-2 infection may not solely relate to the infection itself, but rather may also reflect patients' broader, preexisting neurologic vulnerabilities.

Indexed as

coronaviruselectroencephalographySARS-CoV-2sedationseizure

Identifiers

PMID34163546
PMCPMC8182395
OpenAlexW3108368173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.